Podcasts about Nath

Are you not entertained!? The Wallabies went crazy in Townsville, demolishing Japan 56-17. Nick W, Nath, Finn and Zac react!See omnystudio.com/listener for privacy information.

Are you not entertained!? The Wallabies went crazy in Townsville, demolishing Japan 56-17. Nick W, Nath, Finn and Zac react!See omnystudio.com/listener for privacy information.

Boa terça, angulers! Mais um ano de Angu de Grilo ao vivo na @flipelo, a convite do @sescba. Neste ano, tivemos a honra de conversar com Eliana Alves Cruz (@elialvescruz), jornalista, escritora premiada, roteirista, autora de “Meridiana”, recentemente ganhador do Prêmio Guimarães Rosa de livro do ano de 2025, na categoria Ficção, concedido pela ABL. Eliana também publicou outros seis livros, entre eles “Água de Barrela”, “O crime do Cais do Valongo” e “Solitária”, além dos livros infantis e do recém lançado “Escreviventes”. Nossa conversa passou pela seu trabalho como assessora de imprensa, quando trabalhou diretamente com esportes olímpicos, participando de competições internacionais e olimpíadas, até a transição para se tornar escritora. Falamos de família, da relação com a amiga Conceição Evaristo, das dores da ascensão social no brasil para a população negra, do processo criativo de escrita e sobre “incomodar sonhos injustos”. Rimos, nos emocionamos, nos abraçamos, cantamos. Mais um Angu ao vivo inesquecível! Obrigada a todas as angulers que acordaram cedo para viver essa manhã de Flipelô com a gente! Sirvam-se!Apoie o Angu de Grilo no apoia.se: apoia.se/angudegrilo ou na Orelo: orelo.cc/angudegriloCortes do episódio em vídeo no @angudegrilo no Instagram e Tiktok! Siga, curta e compartilhe! Edição e mixagem: Tico Pro @ticopro_Redes sociais: Claudio Thorne @claudiothorneCortes em vídeo: Nathália Dias Souza @natdiassouza

Join Lead Time+ to continue the conversationThis story simply must be shared.Carter Nath was already serving his rural Iowa congregation when its pastor announced his approaching retirement. As two neighboring Lutheran Church Missouri Synod churches searched for a path forward, Carter was willing to pursue pastoral formation and continue serving the people and community he loved. Then he learned that his age could prevent him from entering the Specific Ministry Pastor program.Carter joins Tim Ahlman and Jack Kalleberg to tell the deeply personal story behind an approaching church closure—and to explain what is truly lost when a rural congregation disappears. This is not merely a conversation about institutional policy. It is about people, communities, pastoral formation, and whether the LCMS can develop faithful local leaders before more Gospel outposts reach their final Sunday.Carter's story deserves to be heard by anyone who cares about rural ministry, the pastoral shortage, and the future of the Lutheran Church—Missouri Synod.If you have a story to share, email: tahlman@cglchurch.orgSupport the show⬇️⬇️⬇️⬇️⬇️⬇️⬇️⬇️⬇️⬇️⬇️⬇️⬇️⬇️⬇️⬇️⬇️Care about the future of the LCMS?Join the LCMS Current! (LCMS Current Events Newsletter)⬆️⬆️⬆️⬆️⬆️⬆️⬆️⬆️⬆️⬆️⬆️⬆️⬆️⬆️⬆️⬆️⬆️To learn more, visit uniteleadership.org

Boa terça, angulers! Abrimos o #343 tratando das crises e entraves diplomáticos das últimas semanas. Milei atacou Lula em convenção do PL, fala de Lula provoca indignação no Governo paraguaio e nova tarifa dos EUA relacionada a investigação sobre trabalho forçado começa a valer para Brasil e outros 60 países. No segundo bloco, a campanha eleitoral que vai começar! Termina nesta quarta o prazo para inscrição das chapas. Flávio e Zema ainda não anunciaram seus vices. Por fim, vendaval no sudeste e chuvas no Sul acendem alerta sobre El Niño e crise migratória entre Marrocos e Espanha inflama e extrema-direita europeia. Sirva-se! Apoie o Angu de Grilo no apoia.se: apoia.se/angudegrilo ou na Orelo: orelo.cc/angudegriloCortes do episódio em vídeo no @angudegrilo no Instagram e Tiktok! Siga, curta e compartilhe! Edição e mixagem: Tico Pro @ticopro_Redes sociais: Claudio Thorne @claudiothorneCortes em vídeo: Nathália Dias Souza @natdiassouza

Download my meditation and wellness app, Swa:aha. https://app.level.game/?c=zSbmYnCheck out BeerBiceps SkillHouse Courses Here - https://linktr.ee/bbskillhouseFollow Dr. Sauradeep Nath's Social Media Handles:- LinkedIn: https://www.linkedin.com/in/sauradeep-nath-074a0a287/ Book: War and Weapon: https://amzn.in/d/0dV8oAy4In this 527th (overall 1032nd) episode of The Ranveer Show, we are joined by Dr. Sauradeep Nath, a historian and researcher specialising in the archaeology, heritage, and military history of Northeast India, and author of "War and Weapon: An Illustrated Legacy of Ahom Military," for one of the deepest history-special conversations we've ever done - on the Ahom dynasty, ancient Assam, and 600 years of a kingdom that was never fully conquered.We talk about ancient Assam's roots in the Mahabharata and Ramayana, the founding of the Ahom dynasty by Sukapha in 1228 CE, the Buranjis and how the Ahoms recorded their own history, the tactics and animals used in Ahom warfare, the courage of women warriors like Mula Gabharu, the long fight against the Turko-Afghans and the Mughals, the Battle of Saraighat and Lachit Borphukan, the mystery of Mayong, and how 600 years of Ahom rule finally came to an end.This podcast is a must-watch for anyone interested in Indian history, the Ahom dynasty, Assamese culture, military history, comparative mythology, and the lesser-known kingdoms of Northeast India.00:00 – Sauradeep Nath On TRS01:54 – Why The Ahom Dynasty Deserves A Mainstream Episode03:17 – Where Assam's History Really Begins04:24 – Pragjyotisha — The Ancient Name Of Assam05:27 – The Origins Of The Kamakhya Devi Temple05:54 – Narakasura & The First Dynasty Of Pragjyotisha06:35 – Banasura's Kingdom In Tezpur07:20 – Bhagadatta & The Mahabharata War08:19 – Elephants In Ahom Warfare11:05 – Mayong — The Occult Village Of India12:35 – Were Ahom Warriors Truly Magical?13:33 – The Story Of Mula Gabharu's Courage19:05 – The Varman Dynasty Begins (350 CE)20:27 – Samudragupta & The Allahabad Pillar Inscription25:43 – Traces Of Buddhism In Ancient Assam29:14 – Bhaskar Varman — Kamarupa's Most Famous King34:09 – The First Turko-Afghan Invasions Of Assam35:46 – Sukapha Founds The Ahom Dynasty (1228 CE)36:23 – The Migration From Mong Mao41:01 – Buranji — The Royal Chronicles Of The Ahoms44:07 – Trained Crocodiles In Ahom Warfare44:43 – War Dogs Used Against The Ahoms53:16 – The Sutiya & Dimasa Kingdoms Before Ahom Expansion59:14 – Queens Who Ruled — Phuleswari Devi1:02:03 – Shields & Ahom Armour1:04:11 – Mula Gabharu's Revenge Against Turbak Khan1:06:46 – How Sanatan Dharma Was Assimilated Into Ahom Religion1:13:57 – The Battle Of Saraighat & Lachit Borphukan1:22:17 – The Battle Of Itakhuli — The Final Mughal Defeat1:29:15 – The Moamoria Rebellion & Decline Of The Ahoms1:31:08 – British Intervention & The Treaty Of Yandabo1:32:33 – The End Of 600 Years Of Ahom Rule

DOWNLOAD HERE: www.pieterleijten.com/yellowfever/ After delivering multiple crowd-moving releases together on Yellow Fever, these artists return with another high-energy weapon designed to set dancefloors on fire. Both having their own distinctive sound, Dawa-X and Nath-D again created a track that combines both that simply refuses to stand still. Their previous collaboration Baby Bounce That Ass became a fan favourite within the Yellow Fever catalog, showcasing exactly why the combination of these two producers works so well: pounding kicks, playful grooves and irresistible bounce.  If you're looking for a track that combines fun, energy and pure dancefloor impact, Bounce That Booty is exactly what you need. Your music on Yellow Fever? Contact us through yellowfever@pieterleijten.com.

This week on the pod we have a double guest special as Jess is joined by Kate Avery and Nath Pearce. Hear how Kate's recent euro races including her win at Monte Rosa 15km went, and catch up on what Nath has been up to since UTA and his plans for the rest of the season. Also hear some listener questions answered and the usual results for the week - plenty of good chats in this one!RESULTS:Australian Outback Marathon Sydney Ultra MarathonsBurralow Bush Run***Don't forget, use code PEAK at https://bix-hydration.myshopify.com/en-au for 20% off Bix products, exclusive to PPP listeners!***Join us on Patreon HEREConnect with us on Instagram @peakpursuits.pod to share your thoughts, questions, and your own trail stories. Until next time, keep hitting the trails and chasing those peak pursuits!Follow Kate: Instagram Follow Nath: Instagram Follow Jess: Instagram | Strava Music from #Uppbeat (free for Creators!):https://uppbeat.io/t/mood-maze/trendsetter License code: K08PMQ3RATCE215R

Boa terça, angulers! Um Angu especial gravado ao vivo, na Flip, na Casa Sesc. Uma conversa incrível com Muniz Sodré, um dos maiores intelectuais do Brasil. Jornalista, sociólogo, professor, obá de Xangô. Um grande Mestre em uma conversa que teve canto em russo, celebração dos encontros da vida e muitas reflexões sobre o Brasil. Que privilégio e honra! Sirva-se! Apoie o Angu de Grilo no apoia.se: apoia.se/angudegrilo ou na Orelo: orelo.cc/angudegriloCortes do episódio em vídeo no @angudegrilo no Instagram e Tiktok! Siga, curta e compartilhe! Edição e mixagem: Tico Pro @ticopro_Redes sociais: Claudio Thorne @claudiothorneCortes em vídeo: Nathália Dias Souza @natdiassouza

Boa terça, angulers! Episódio #341 no ar. Abrimos comentando o tarifaço dos EU que foi mesmo confirmado e entra em vigor já nesta quarta-feira. No segundo bloco, Espanha campeã do mundo! A Copa acabou e o que fica são as histórias emocionantes de superação e sobrevivência das famílias de jogadores filhos da diáspora. Por fim, os pop-ups da semana. Acreditam que a Europa está descobrindo o ar-condicionado? Parece piada, mas é a crise climática! Sirva-se! Apoie o Angu de Grilo no apoia.se: apoia.se/angudegrilo ou na Orelo: orelo.cc/angudegriloCortes do episódio em vídeo no @angudegrilo no Instagram e Tiktok! Siga, curta e compartilhe! Edição e mixagem: Tico Pro @ticopro_Redes sociais: Claudio Thorne @claudiothorneCortes em vídeo: Nathália Dias Souza @natdiassouza

Everyone tells you your business is different too. Your market, your model, your members, your suburb. If that story is the reason you haven't fixed your intro offer or built your rollover process, grab the free Vision Book Template that Nath used to rebuild his business: https://bit.ly/p-vision-book-template And if you want to see exactly how this playbook maps onto your studio, book a discovery call here: https://bit.ly/p-your-studio-check-up Follow Geronimo Unfiltered: Spotify Apple Podcasts YouTube Instagram A dog training business joined a gym growth academy and doubled to 100k months in six months. This is the episode that kills the "my business is different" excuse for good. Every week someone tells me their market is unique, their clients are special, and the model wouldn't work for them. Then Nath called my sales team, said "I'm not your avatar, but I want in," and joined a coaching program built for gym owners with a dog training business. My first reaction was to ring my sales team and ask what the hell they were doing. Six months later he's doubled the business on the exact playbook we teach studio owners, with nothing watered down or adapted for dogs. What almost stopped him had nothing to do with the industry, and everything to do with what he was refusing to let go of. That part of the story is the reason to listen to the whole thing. In this episode you'll hear: The exact model: a four week Calm Dog Kickstart, a 70% rollover rate, and a $148 a week membership (yes, for dogs) The moment he rang his coach to quit at 75k months, and the answer that turned it into 56% growth in two months The identity shift from doing the work to owning the business, and what was actually underneath the refusal to let go The 70% rule in action: he launched his vision book, lost four of his twelve staff in a week, and kept going anyway Why "you can't teach an old dog new tricks" is a lie, in dogs and in business owners (including a live fix for Doza's whinging Labradoodle) If this one hit, binge this next: STOP Playing Small. It's the other half of this story, because Nath's real unlock wasn't the kickstart or the rollover process, it was refusing to stay at the level everyone said was already good. Nath came in at 50k months running a dog training business, and the same frameworks took him past 100k with a mission to save 10,000 dogs. If he can do that in an industry we'd never coached before, imagine what the playbook does inside an actual studio. Book your discovery call here: ⁠https://bit.ly/p-your-studio-check-up⁠ CHAPTERS 00:00:00 The dog training business that broke our avatar 00:02:03 "I'm not your avatar, but I want in" 00:04:50 The business model: entry points and the Calm Dog Kickstart 00:07:47 Inside the $148 a week membership 00:11:31 Recap: 50k to 75k, then the bottleneck 00:12:28 The call with Rob that nearly ended it 00:14:47 Why he couldn't let go: the identity underneath 00:16:46 PSA: "my business is different" 00:20:58 The mission: 10,000 dogs 00:22:20 The 70% rule: losing a third of the team 00:24:57 What's next: the 10k Dogs podcast 00:26:33 Live demo: fixing Duke's whinging 00:28:44 Burnout, Separation Sunday and family 00:33:55 Moving the goal: 300k months 00:37:08 Business principles, not business models

Check out our Nolan-esque use of non-linear plotting as we interrupt our chronological journey through the films of Christopher N to take in the director's newly released epic, The Odyssey. Praise Zeus, we did it! We got Rob to the cinema, and he stayed there until the film was over. But what did he - and Nath, and Dave - make of this take on Homer's epic tale? Even more crucially, how did Dave - a man who runs a social media agency specialising in the entertainment industry - manage to watch this extensively marketed film without even knowing who was in the cast? How does it compare to Nolan's other epic big screen adventures? And can it possibly compete with the Ducktales version of the story from the episode 'Home Sweet Homer,' which features duck sirens?Find out by simply listening to this podcast - or risk the wrath of Podseidon!Nolan mailbag is coming - join in and email your thoughts, questions and opinions to redshirtcinemaclub@gmail.comMeanwhile the rest of the schedule for RSCC's Nolan summer looks like this:Dunkirk (Patreon-exclusive) - 22nd JulyTenet - 27th JulyOppenheimer - 3rd AugustCaptain's Choice - 5th August (Patreon-exclusive)Batmail Begin Hosted on Acast. See acast.com/privacy for more information.

A rom com job A crumpet fantasy Nath is hysterical Text from mum @thebuckuppodcast @katelangbroek @nathvalvo Our money back guarantee is that you're going to feel better at the end of this podcast than you did at the beginning See omnystudio.com/listener for privacy information.

In this episode we speak with Shivya Nath and her new book Rootless and Restless. We also talk about responsible travel, how its meaning has changed with time and what we can do to ensure that our choices give back.Connect with Shivyahttps://www.instagram.com/shivya//https://theshootingstar.substack.com/Buy Rootless and Restless https://www.penguin.co.in/book/rootless-and-restless/Share your thoughts and feedbacks⁠⁠⁠https://www.instagram.com/theresponsibletravelpodcast/⁠⁠⁠⁠⁠⁠anshul.akh99@gmail.com⁠⁠⁠Youtube: ⁠⁠⁠https://www.youtube.com/c/DailyPassenger/videos⁠⁠⁠Instagram: ⁠⁠⁠https://www.instagram.com/daily.passenger/⁠⁠⁠

Boa terça, angulers! Abrimos o #340 comentando a operação da PF que mirou Valdemar da Costa Neto e Eduardo Cunha. Os dois são suspeitos de terem interferido na destinação de verba para emendas parlamentares. No segundo bloco, a reta final da copa do mundo e nossas impressões sobre a semana que passou. Tá acabando! Por fim, os pop-ups da semana: EUA baterá o martelo sobre novo tarifaço nesta quarta-feira; bombardeios entre EUA e Irã voltam, apesar do acordo de paz; prefeitura do Rio proíbe propaganda de bets em espaços públicos. Sirva-se! Apoie o Angu de Grilo no apoia.se: apoia.se/angudegrilo ou na Orelo: orelo.cc/angudegriloCortes do episódio em vídeo no @angudegrilo no Instagram e Tiktok! Siga, curta e compartilhe! Edição e mixagem: Tico Pro @ticopro_Redes sociais: Claudio Thorne @claudiothorneCortes em vídeo: Nathália Dias Souza @natdiassouza

Where do we go from here? We don't bloody know. Nick H and Nath give a reaction to Wallabies-France. See omnystudio.com/listener for privacy information.

The boys have lifted the curse and apparently that'll help the Wallabies against France... with Declan Meredith now set for a baptism by fire at Suncorp Stadium. The Nicks and Nath talk the Wallabies squad, Nations Championship, U20s, Tom Hooper going tot he Reds, and more. WARNING: naughty wordsSee omnystudio.com/listener for privacy information.

What happens when traditional depression treatments stop working? Could a single psychedelic-assisted therapy session create lasting change? What does the latest research reveal about psilocybin's potential in mental healthcare? In this episode, Joe Sanok speaks with Compass Pathways CEO Kabir Nath about the emerging role of psilocybin-assisted therapy in treating treatment-resistant depression (TRD). They discuss the latest clinical research, how psychedelic therapy is being studied, and its potential to transform mental healthcare.

Boa terça, angulers! Não deu! Brasil eliminado da Copa do Mundo 2026. Foi com esse desabafo de frustração e indignação que abrimos o #339. No segundo bloco, pop-up do novo tarifaço de Trump sobre o Brasil. A última rodada de argumentação e negociações começou. Em paralelo, Flávio Bolsonaro tenta, de novo, usar os EUA para interferir na corrida eleitoral e seguem os de dobramentos dos embates de Flávio com Michelle. Sirva-se! Apoie o Angu de Grilo no apoia.se: apoia.se/angudegrilo ou na Orelo: orelo.cc/angudegriloCortes do episódio em vídeo no @angudegrilo no Instagram e Tiktok! Siga, curta e compartilhe! Edição e mixagem: Tico Pro @ticopro_Redes sociais: Claudio Thorne @claudiothorneCortes em vídeo: Nathália Dias Souza @natdiassouza

Boa terça, angulers! Abrimos o #338 comentando a treta entre Michelle e Flávio. Familia Bolsonaro cada vez mais rachada. Também falamos sobre Jaques Wagner na mira da PF por recebimento de vantagens indevidas em troca de favorecimento ao Banco Master no Congresso. No segundo bloco, momentos e emoções de copa do mundo, os terremotos na Venezuela, a situação de Cuba sem petróleo. Sirva-se! Apoie o Angu de Grilo no apoia.se: apoia.se/angudegrilo ou na Orelo: orelo.cc/angudegriloCortes do episódio em vídeo no @angudegrilo no Instagram e Tiktok! Siga, curta e compartilhe! Edição e mixagem: Tico Pro @ticopro_Redes sociais: Claudio Thorne @claudiothorneCortes em vídeo: Nathália Dias Souza @natdiassouza

In this episode, Dr. Jordan Whatley and Dr. Temara Hajjat talk to Dr. Katie Larson-Nath, Pediatric Gastroenterologist and Division Director at the University of Minnesota M Health Fairview Masonic Children's Hospital, who specializes in pediatric nutrition and leads the Intestinal Rehabilitation Program. We talk about the recently published joint AAP/NASPGHAN Clinical Practice Guideline for Diagnosis and Management of Faltering Weight, a new term that replaces "failure-to-thrive".Learning objectives1.     Understand the basis for the change in terminology from “failure-to-thrive” to “faltering weight” per the 2026 joint AAP/NASPGHAN Clinical Practice Guideline2.     Describe the defining criteria for a diagnosis of faltering weight3.     Understand the recommended comprehensive evaluation and management of children with faltering weightLinksJoint AAP/NASPGHAN Clinical Practice Guideline for Diagnosis and Management of Faltering WeightWHO Weight Gain Velocity Standards2015 AND/ASPEN Consensus Statement for the Identification and Documentation of Pediatric Malnutrition (Undernutrition)Send us Fan MailSupport the showThis episode may be eligible for CME credit!  Once you have listened to the episode, click this link to claim your credit.  Credit is available to NASPGHAN members (if you are not a member, you should probably sign up).  And thank you to the NASPGHAN Professional Education Committee for their review!As always, the discussion, views, and recommendations in this podcast are the sole responsibility of the hosts and guests and are subject to change over time with advances in the field.Check out our merch website!Follow us on Bluesky, Twitter, Facebook and Instagram for all the latest news and upcoming episodes.Click here to support the show.

Boa terça, angulers! #337 no ar! Abrimos comentando a nova pesquisa Quaest que apontou perda de apoio de Flávio Bolsonaro entre evangélicos, mulheres, jovens, no sudeste, entre outros grupos. Desde março, Lula e Flávio apareciam em empate técnico nas simulações do segundo turno. Agora, Lula abriu vantagem de seis pontos. No segundo bloco, nossas impressões, surpresas, deleites e críticas assistindo à Copa do Mundo. Por fim, pop-ups internacionais: EUA e Irã chegam a acordo de paz, que será assinado na sexta-feira; Peru segue com sua eleição presidencial indefinida e com pedido de recontagem dos votos: Reuni Unido quer proibir o acesso de menos de 16 anos a redes sociais; e a maravilhosa peça “Viva! vida!”, monólogo de Regina Casé com texto de Estevão Ciavatta. Sirva-se!Apoie o Angu de Grilo no apoia.se: apoia.se/angudegrilo ou na Orelo: orelo.cc/angudegriloCortes do episódio em vídeo no @angudegrilo no Instagram e Tiktok! Siga, curta e compartilhe! Edição e mixagem: Tico Pro @ticopro_Redes sociais: Claudio Thorne @claudiothorneCortes em vídeo: Nathália Dias Souza @natdiassouza

Super Rugby Pacific ends in Australia for 2026, not with a bang but a whimper. Nick W and Nath rip the band aid off and sit on the cuck chair to discuss the Reds and Brumbies, before exorcising the bad news by talking Super Rugby Women's and the Aussie 7s win in France. WARNING: bad metaphors and explanationsSee omnystudio.com/listener for privacy information.

Boa terça, angulers! Abrimos o #336 comentando o novo tarifaço imposto por Trump ao Brasil. Ao que tudo indica, vem aí em junho. No segundo Globo, o caso Henry Borel, a condenação de Jairinho e o perdão judicial à Monique. Inacreditável. Por fim, as tensões geopolíticas da copa do mundo já começaram! E as eleições presidenciais extremamente acirradas no Peru. Sirva-se!Apoie o Angu de Grilo no apoia.se: apoia.se/angudegrilo ou na Orelo: orelo.cc/angudegriloCortes do episódio em vídeo no @angudegrilo no Instagram e Tiktok! Siga, curta e compartilhe! Edição e mixagem: Tico Pro @ticopro_Redes sociais: Claudio Thorne @claudiothorneCortes em vídeo: Nathália Dias Souza @natdiassouza

Support us on Patreon

A New York Cemetery Was Hiding Over 5 Million Burrowing Bees, One of the World's Largest Concentrations A New York cemetery was hiding 5.5 million bees underground Contact the Show: coolstuffdailypodcast@gmail.com Learn more about your ad choices. Visit megaphone.fm/adchoices

Boa terça, angulers! Um #335 recheado de assunto! Abrimos comentando a votação histórica na câmara que aprovou o fim da escala 6x1 e a redução da jornada de trabalho. O texto segue para votação no Senado, ainda sem previsão. No segundo bloco, a visita de Flávio Bolsonaro a Daniel Vorcaro, enquanto o ex-banqueiro ainda cumpria medidas cautelares após sua primeira prisão. Ainda no tema, Cláudio Castro foi alvo de operação que mira aportes em fundos do Banco Master. Além disso, o encontro de Flávio com Trump e a classificação do CV e do PC como organizações terroristas estrangeiras. Por fim, uma passada no primeiro turno das eleições presidenciais da Colômbia e as dicas culturais da semana que incluem a turnê do Martinho da Vila e Martnalia, entre outras. Sirva-se!Apoie o Angu de Grilo no apoia.se: apoia.se/angudegrilo ou na Orelo: orelo.cc/angudegriloCortes do episódio em vídeo no @angudegrilo no Instagram e Tiktok! Siga, curta e compartilhe! Edição e mixagem: Tico Pro @ticopro_Redes sociais: Claudio Thorne @claudiothorneCortes em vídeo: Nathália Dias Souza @natdiassouza

Two Aussie sides are in the finals... but how far will they get? Nick H, Nath and Nick W get honest about the Reds and Brumbies' chances after mixed form over the last few weeks, plus talking Moana Pasifika, victory in the Sevens, and Super Rugby Women's. DKO INSTA: https://www.instagram.com/thedroppedkickoff/ DKO TWITTER: https://x.com/DroppedKickOff_ WARNING: graphic analogies, honest opinions and naughty wordsSee omnystudio.com/listener for privacy information.

Subscribe on LiSTNR: https://play.listnr.com/podcast/fifi-fev-and-nickSee omnystudio.com/listener for privacy information.

Boa terça, angulers! Finalmente, chegamos em São Paulo com nosso Angu ao vivo #334. Vivemos uma tarde inesquecível aprendendo e reverenciando o gigante @neilopesoficial. Cantor, compositor, escritor, advogado, dicionarista, ilustrador, poeta, ficcionista, estudioso, um dos maiores intelectuais do Brasil. 84 anos de muita sabedoria. Uma aula de Angu de Grilo. Sirva-se! Apoie o Angu de Grilo no apoia.se: apoia.se/angudegrilo ou na Orelo: orelo.cc/angudegriloCortes do episódio em vídeo no @angudegrilo no Instagram e Tiktok! Siga, curta e compartilhe! Edição e mixagem: Tico Pro @ticopro_Redes sociais: Claudio Thorne @claudiothorneCortes em vídeo: Nathália Dias Souza @natdiassouza

Boa terça, angulers! Abrimos o Angu #333 comentando as mensagens trocadas entre Flávio Bolsonaro e Daniel Vorcaro, que escancaram relação pessoal e íntima entre os dois. No segundo bloco, governo age em busca de popularidade e se recuperada. Por fim, as projeções para o El Nino, que deve começar em junho; a morte de Noca da Portela, aos 93 anos; e as dicas culturais d semana. Sirva-se! Apoie o Angu de Grilo no apoia.se: apoia.se/angudegrilo ou na Orelo: orelo.cc/angudegriloCortes do episódio em vídeo no @angudegrilo no Instagram e Tiktok! Siga, curta e compartilhe! Edição e mixagem: Tico Pro @ticopro_Redes sociais: Claudio Thorne @claudiothorneCortes em vídeo: Nathália Dias Souza @natdiassouza

Super Rugby is finishing with a flourish. With Nick W off with the tradies, Nick H and Nath chew the fat on the Tahs cleaning up in Suva and the Force chasing a dream... and do some number crunching to see what finals might look like. WARNING: a LOT of editing was required. Imagine what we had to cut out. Farrell nailing a lineout: https://x.com/premrugby/status/2055734778905731101?s=46See omnystudio.com/listener for privacy information.

Advances in immunotherapies for multiple sclerosis and related disorders have increased the risk of infections and raised important questions about vaccination efficacy. This episode reviews infection risks across treatment classes, emphasizes the importance of monitoring and patient education, and discusses optimal vaccine timing to preserve protective immune responses. In this episode, Aaron L. Berkowitz, MD, PhD, FAAN, speaks with Avindra Nath, MBBS, FAAN, coauthor of the article "Infection Risk and Vaccine Considerations in Multiple Sclerosis and Related Disorders" in the Continuum® April 2026 Multiple Sclerosis and Related Disorders issue. Dr. Berkowitz is a Continuum® Audio interviewer and a professor of neurology in the Department of Neurology at the University of California, San Francisco, in San Francisco, California. Dr. Nath is the chief of the Section of Infections of the Nervous System at the National Institute of Neurological Disorders and Stroke, National Institutes of Health, in Bethesda, Maryland Additional Resources Read the article: Infection Risk and Vaccine Considerations in Multiple Sclerosis and Related Disorders Subscribe to Continuum®: shop.lww.com/Continuum Earn CME (available only to AAN members): continpub.com/AudioCME Continuum® Aloud (verbatim audio-book style recordings of articles available only to Continuum® subscribers): continpub.com/Aloud More about the American Academy of Neurology: aan.com Social Media facebook.com/continuumcme @ContinuumAAN Host: @AaronLBerkowitz Full episode transcript available here Dr Berkowitz: Over the last decades, there has been a revolution in the treatment of multiple sclerosis, neuromyelitis optica spectrum disorder, and other immune-mediated neurologic conditions with countless new, highly effective medications. However, with every new treatment comes new risks; and in the case of immunomodulatory therapy, many of those risks relate to infection. Today, I have the privilege of talking with an expert on this topic, Dr Avindra Nath, about the infectious risks of treatments for multiple sclerosis and other immune-mediated neurologic disorders.  Dr Jones: This is Dr Lyell Jones, Editor-in-Chief of Continuum. Thank you for listening to Continuum Audio. Be sure to visit the links in the episode notes for information about earning CME, subscribing to the journal, and exclusive access to interviews not featured on the podcast.  Dr Berkowitz: This is Dr Aaron Berkowitz, and today I'm interviewing Dr Avi Nath about his article on vaccine considerations and infection risk in multiple sclerosis and related disorders, which he coauthored with Dr Amit Bar-Or. This article appears in the April 2026 Continuum issue on multiple sclerosis. Welcome to the podcast, Dr Nath, and could you please introduce yourself to our audience?  Dr Nath: Thanks very much for inviting me to this podcast. I'm absolutely delighted to have the opportunity to discuss our areas of interest and expertise related to infections and vaccinations for MS patients. My area has been studying the infections of the nervous system since the beginning of the AIDS pandemic, and over the years and decades, we've developed expertise related to various types of CNS infections. That includes ones that are developing in individuals who have immune compromise due to a variety of different reasons. Dr Berkowitz: Fantastic. Well, glad to have the opportunity to speak with you today. When I was in medical school---and you were my attending, actually, we were just reminiscing, which we probably think was not that long ago, but is now over twenty years ago---there were just two medications for MS, right? Beta interferon and glatiramer acetate. And now we have over a dozen, and it's amazing to think of all the progress in these last two decades, as well as for related diseases like NMO. I don't think we even had the aquaporin-four biomarker, right, when I was working with you as a med student in the early 2000s. Dr Nath: And that certainly dates me a lot.  Dr Berkowitz: Both of us.  Dr Nath: Yeah.  Dr Berkowitz: Of course, with all these new treatments, these have been amazing advances for our patients, right? But these come with new treatment-related risks to monitor for with the immunomodulatory medications for MS and related disorders. And one of those most important risks is that of infection. So, your article reviews the potential infectious complications of medications used to treat MS, NMO, etc, and also covers considerations related to thinking about vaccines in this patient population. So, as the MS treatment landscape grows, I can say as a general neurologist, keeping up with all these medications and what to screen for and what to worry about and when to vaccinate just becomes more challenging every year. And your article has so many helpful tables, some organized by medicine, some organized by- sorry, medication, some organized by infection, some by vaccines. So, this is gonna be a great resource for our providers to print out and tape up in their clinic rooms. We won't be able to get into all the depth and detail that you have in this article today, but I do want to focus on some of the key points here related to the common medications we use for MS and which infections to think about and which vaccine considerations we might need to keep in mind for these medications. But before we delve into the drugs, I just wanna ask you more broadly, you talk in the article about the challenge of patients with immune-mediated diseases who are on immunomodulatory therapy being at risk for both flares of their disease and for infections; and these infections can present somewhat atypically, right, in immunomodulated hosts, to maybe coin a term you can correct me on, because they can't mount the full inflammatory response. So how do you approach new symptoms in patients on these immunomodulatory medicines as far as distinguishing disease flare from a treatment-related infection?  Dr Nath: So, I have to say that although a lot of new treatments have come along for MS, and they've really, you know, improved the outcome tremendously and there are so many different options, it has also kept people like me relevant because they cause a lot of various types of infections, and so keeps me in business all the same. But just as you mentioned, there's so many of them, even I have difficulty keeping track of what does what. So, you do need to be able to refer back to published literature, and the tables, I hope, will be quite useful in that regard. You're absolutely right, and you can get new infections, you can get reactivation of existing infections, and you can get atypical presentations of various types of infections that you may not normally think of. So that presents multiple challenges to the treating physician. The other interesting thing about MS is, just as you mentioned, that you already have CNS lesions to begin with. Now, on top of it, you have an infection, so now how to sort out what is the existing disease and what is the infection, it can again become challenging. But one thing is for sure: all these infections are caused by an organism. So, what you really need to do is, the underlying diagnostic is to demonstrate the presence of the organism. Whether you demonstrate it depending on the infection in the spinal fluid or in the brain or, you know, some peripheral organ system, that is going to be key to making the diagnosis. So, all your clinical acumen is good, but that alone may not be sufficient. Dr Berkowitz: Very good. So, when you see a, a patient now who has a new neurologic symptom in the context of an immune-mediated disease who's on immunomodulatory therapy, what goes through your mind? Are you thinking this disease and this drug, and sort of what are the infections, and does the syndrome match? Or are you thinking, you know, you can't always rely on the imaging to distinguish between, say, a flare of an MS and PML because white matter lesions could look similar? How do you sort of approach this scenario when it comes up?  Dr Nath: So, you're right. You have to keep an open mind so that even though you know some infections are more likely to occur with certain types of medications, that doesn't mean that others cannot occur. So, I think when you first see the patient, you should not jump to conclusions, but rather have an open mind. But yes, for example, your patient is on natalizumab, the chances of PML are going to be high. It's a very interesting drug. It does not cause immune compromise in the periphery, but what it's doing is preventing these cells from getting into the brain. So, because then it's acting at the blood-brain barrier. So that means that organisms that are already present in the brain have an opportunity to get reactivated. Turns out you don't have a lot of organisms in the brain, except JC virus seems to be one of them that does somehow, in some individuals, manage to reside out there. And so that can get reactivated. It can get reactivated in the periphery and then enter the brain, too. So, where the very specific mutations have to occur in that virus in order to take residence in the brain. That would be a suspicion that you might have, and MRI can be useful in, again, helping you think about that possibility. If you have typical lesions involving the U fibers, they're demyelinating, usually you do not have much edema around them because patient is immune compromised, but certainly within the brain in these individuals. And so, then you need to demonstrate the organism. The demonstration of the organism should be in the spinal fluid and not in the blood because in the virus, it can-- is reservoir in the kidneys and in the lymph nodes, and periodically it'll shed into the blood. Detection of the organism in the blood can be a false positive, but in the spinal fluid, it shouldn't be there unless you have an infection. Or if you cause a traumatic tap, I guess, if a patient is viremic, that's a possibility, but those are extremely rare. So at least for PML, that's the way that you would diagnose it. Now, you can develop, for example, if an individual is on fingolimod, you can get a wide variety of infections. Here it's a totally different type of mechanism of action. Here the cells are trapped within the lymph nodes, so that means now your entire periphery is immune compromised, right?  So here you can get viral infections, bacterial infections, fungal infections. So here, if a patient presents with new neurological symptoms, you have to have a really open mind for all these possibilities. Now, let's say a patient was on dimethyl fumarate, and dimethyl fumarate causes neutropenia early on. So here you have to worry about an individual developing bacterial infections, so latent tuberculosis or bacterial meningitis can occur in these individuals. That's something to keep in mind. It's not that other infections cannot occur with dimethyl fumarate, you can see PML and other things too, but the chances of bacterial infections are greater. So, you got to make sure that you draw all the cultures for that purpose. Similarly, if you're on a complement inhibitor, like a C5 inhibitor or the thing that I could use in NMO, there are the chances of meningococcal meningitis. So, these patients, you need to prevaccinate them before you start these kinds of treatments and look for that possibility. When you suspect bacterial infections, particularly acute bacterial meningitis, there time is of essence. Also, in some of the acute viral infections, for example---herpes encephalitis is another one---you have to be so careful, and if you suspect any of them, even if they're with possibly atypical manifestations, you treat first and then diagnose later, and draw all your cultures, whatever you need to, and just treat them. And these infections can also cause cerebral edema, so one has to be careful about doing spinal taps in these individuals. You want some kind of neuroimaging before you do them. In the days when we didn't have neuroimaging, we used to say, "Okay, if your patient has focal neurological signs or is comatose, you don't do it." But these days, you can get imaging very quickly and very easily. All the-- Because of our stroke management, we've learned how to do them so quickly. So, I think there's little excuse not to do imaging and prevent herniation from occurring.  Dr Berkowitz: That's very helpful. So, using the information we know about the drug, and we're going to rapid-fire review some of that in a bit to know what infections the patient is susceptible to, but acknowledging that any patient can get any infection, right? Whether they're on particular medications or not. And then if you're not sure, based on the neuroimaging, which as you said, is helpful, but not always helpful in distinguishing between infections and flares or, as you said, in the case of meningitis, encephalitis, early on at least, especially in immunocompromised or immunomodulated, quote unquote, patient might not see the typical imaging. So really, when safe, getting CSF or cultures, PCRs, and other infectious studies too is really gonna be the definitive diagnostic maneuver here. Is that fair summary across the board?  Dr Nath: I think you said that absolutely right. And you summarized that correctly. And, you know, thing about infection, a lot of neurological diseases are, you know, diagnosed by clinical acumen, like your Parkinson's and Alzheimer's and others. Think about infections is caused by an organism, demonstrate the organism, right? That should be your goal. It doesn't mean that clinical acumen is not important, but here you have an opportunity to demonstrate the organism, so you should depend upon that.  Dr Berkowitz: Okay. Well, you gave us a nice segue by talking about some of the infections to worry about with some of the medications. So what I'd like to do now for the sort of second half of our interview here is to go through some of the more common medications used for MS, and if we have time, for NMO, and just sort of go kind of rapid fire here, and for each medication, if you can tell us the kind of top infectious concerns and whether when to consider them or what screening needs to take place before or during administration of the medication, and then any vaccine considerations we should be aware of. Some of these will obviously be quite short depending on the medicine. So, going back to the two medications I alluded to earlier that were the only ones in play when you and I last saw each other on the wards when I was a medical student, beta interferon, glatiramer acetate, any infections or vaccine considerations with these medications?  Dr Nath: No, I think they're probably your safest medications now as far as immunomodulatory therapies are concerned. These two, and IVIG, if you ever use them, are probably the safest, do not require any vaccine considerations, per se. Dr Berkowitz: Perfect. Okay. So, moving on to fingolimod and others in the sphingosine-one phosphate receptor modulator family, what are the infectious considerations? Any prescreening or vaccination considerations?  Dr Nath: I think all your patients should be prescreened for antibodies to JC virus, because there is a risk for PML, and those who are positive should be closely monitored. So, it's not an absolute contraindication for using these medications, but they just require closer monitoring. With this class of drugs, PML is of consideration. Also, these varicella-zoster virus infection, yeah, with that you can develop zoster encephalitis or myelitis. It can present with motor symptoms as well, which can be atypical. You don't usually see them otherwise in immune-competent individuals. So, varicella-zoster, sometimes you can develop encephalitis, also vasculitis with varicella-zoster, so one has to be careful. So, getting the shingles vaccine can be actually very helpful to prevent these things. And then some patients can even develop herpes simplex encephalitis also, and that can be extremely atypical. So, they don't- they can involve the basal ganglia, can involve the brain stem and cerebellum. So again, your index of suspicion should be very high. Interestingly, although HSV encephalitis has been associated with NMDA receptor encephalitis, those reports of NMDA receptor encephalitis have not been published yet with NMS patients. Not sure why, maybe they just have been missed. But that doesn't seem to be a major concern. And then there are a whole host of other infections that can occur with this class of drugs, and that can include toxo; fungal infections, particularly crypto. There's a case report of histoplasmosis; hepatitis virus, particularly hepatitis C; and then the poxvirus is a good example. You can get molluscum contagiosum; warts with papillomavirus; you can get atypical mycobacteria; and even Kaposi sarcoma, which is HHV8. So, there's a huge variety of infections with the sphingosine one phosphate receptor modulators.  Dr Berkowitz: And any- aside from screening for JC virus before initiating these, any- and then continuing to monitor for JC antibody index, any other considerations as far as labs to send, monitoring before or on the drug or vaccine considerations for patients on fingolimod and the others in this category, siponimod, etcetera?  Dr Nath: Yeah, there are a lot of things to consider. All the details are really available in the chapter if you look at them. But briefly, all the things that one could potentially vaccinate patients for, all these infections I mentioned, one should do so. The timing is critical so that if you can do it before treatment, I think, before starting treatment, that is absolutely important. And you got to give them at least, you know, two to three weeks for these vaccines to take effect before starting your medication. If your patient already arrives on a medication, then you got to play this game of you know, before the next dose, give them again two to three weeks before the next dose and start vaccinating them and get all the vaccines in. Broadly, about the things to worry about the vaccines are you have live vaccines, and you've got the inactivated vaccines or the subunit vaccines. You have to be careful with live vaccines, because if your patient is immunocompromised, that virus can sometimes itself cause harm. For example, you know, yellow fever is one, and there you can develop encephalitis from it. Measles, mumps, rubella, these are all live vaccines. Now, the good thing is that a lot of us have been immunized very early in childhood, but that may not be the case any longer. And so, these things, one has to be very careful with when you're giving live vaccines, that we want to avoid them as much as possible, and individuals are gonna be immune-compromised. But all the others, meningococcus, for example, you should- the HPV vaccines, the varicella zoster vaccines, all these things, you've got to pre-vaccinate and make sure that they have an antibody response to them before starting immunocompromising therapy. Dr Berkowitz: Perfect. Okay, moving on to some of the other orals. What infectious and/or vaccine considerations do we have with teriflunomide?  Dr Nath: Okay, yeah. Teriflunomide is a very interesting drug. It's relatively safe. There is concern about the possibility of varicella zoster infection, people have reported that, and also tuberculosis. But PML is extremely rare, if not at all, and we haven't seen herpes encephalitis quite yet.  Dr Berkowitz: Got it. How about dimethyl fumarate? Dr Nath: Yeah. So dimethyl fumarate is... as I mentioned earlier, it's interesting because it causes this neutropenia. It's transient, but it occurs early on, and these patients can be at risk of PML, although small. They can develop varicella zoster virus infection, herpes encephalitis, and also fungal infections. For example, cryptococcal infection has been reported with dimethyl fumarate. Dr Berkowitz: Okay. We've spoken a bit about natalizumab and PML, and you have extensive information on this in your article, and I'll defer the reader to that. But for natalizumab, what are the key points every neurologist should know about natalizumab and PML as far as from the practical perspective, screening, frequency of screening, when to worry, when to not use natalizumab at all in the first place based on what you find in your screening for JC virus? What are the key points every neurologist should know?  Dr Nath: Uh, yes. You bring up an important point, and that is all patients should be monitored for JC virus. If they're JC virus-negative, so that's your most ideal patient to go on natalizumab, but that doesn't mean they cannot get infected with the virus. In fact, there's an interesting study claiming that, you know, patients, when they get these infusions, they're all sitting in the same room getting infused. Some have JC virus, some don't have JC virus, and so there's the potential that we may be aiding the transmission here in some way or another. The virus is an interesting one. It comes out in urine, and then it's spread through oral contamination, gets into the tonsils, and then spreads from there to your marrow and resides in the kidney and the marrow, as well as the lymph nodes, forever. So, you, you have to monitor these patients to see that during the course, even if they're negative, they could turn out positive. So, every six months or a year, an antibody test should be done on all patients irrespective. If a patient already has antibodies, that's not an absolute contraindication. It just means you've got to monitor them closely for development of new symptoms, and if, whenever there are new symptoms, don't just assume this is due to MS, but just make sure the MRI is done with and without contrast. The- and if there's still a suspicion, that you do a CSF evaluation for JC virus. Just detecting, looking for JC virus in the blood, a rising titer is another thing that can help you. And so, the titer is also important. And the reason you have rising titers is it means that there's an infection that's already occurred in the brain, and the immune system is reacting to that infection by increasing titers. But that alone is not sufficient to make the diagnosis. You still- that gives you an index of suspicion. You've got to then do the MRI and the spinal tap to, you know, be absolutely certain. So, each patient is a little bit different, so the way you monitor them is going to depend on where they are. You know, if they've had prior immunomodulatory therapy before starting natalizumab, or if they're on natalizumab for more than two years, then the chances of PML are much greater, so you may want to monitor them more closely. Uh, they never had any prior immunomodulatory therapy, you're just starting natalizumab, maybe once a year is sufficient. So, I think you've got to tailor it depending on what your risks are for each patient. Dr Berkowitz: Perfect. That's very helpful. And again, you write extensively about PML and natalizumab and PML considerations in your article. So, for a more detailed and in-depth discussion of what we just discussed, definitely hope readers will take a look at your article. Okay. Last but not least---certainly not least, 'cause we're using these probably, it seems, the most commonly in many places I've worked---rituximab, ocrelizumab are B-cell therapies for MS. What are some of the infectious and vaccine considerations related to these infusion medications?  Dr Nath: So, there's concern for PML with anti-B-cell therapies also, maybe not to the same degree as natalizumab, but the same principles should be applied. A lot of people think that these are relatively safe. I don't think so. I think we see enough number of patients on B-cell therapies with PML. So, I would use the same caution because these infections are... you know, can be fatal. So, one should be very careful, even with anti-B-cell therapies. And just with natalizumab, you also have the risk of VZV infection causing shingles. HSV1 has been reported, but there's another interesting complication that has been reported with anti-B-cell therapies, and that is severe West Nile encephalitis. And as mosquitoes-borne diseases are getting more and more prevalent, and we're seeing West Nile cases erupting every summer, I think one's got to be, you know, very cognizant of the fact that this can occur. These patients should take precautions to prevent mosquito bites from occurring and not expose themselves to areas where they could be at risk for it. Unfortunately, there is no vaccine for it and no specific treatment for West Nile. So, all one can do is use prevention strategies for mosquito bites.  Dr Berkowitz: Yeah, I'm glad you mentioned that. I think the only really truly severe neuroinvasive cases I've seen of West Nile virus have indeed been in patients who were being treated with B-cell therapy. Not, if I'm remembering correctly, for immune-mediated disease, but for a lymphoma, so probably other confounding factors there. But yeah, it's a disease we learn about and think about, but I've only seen the most severe cases in patients who had abnormal immune systems, so I'm glad you flagged that. This has been a very helpful discussion, and I've learned a lot from you. I learned a lot from your article, just as I did when you were my attending some 20-something years ago on the wards when I was a medical student. So, it's good to continue learning from you through your writing and research, and today from getting to talk to you again. I encourage our readers to read your article and to bookmark those tables for when these considerations come up for your patients on these immunomodulatory therapies and you're wondering which infections to worry about and how to manage vaccines in this patient population. So again, today I've been interviewing Dr. Avi Nath about his article on vaccine considerations and infection risk in multiple sclerosis and related disorders, which he wrote with Dr. Amit Bar-Or. This article appears in the April 2026 Continuum issue on multiple sclerosis. Be sure to check out Continuum Audio episodes from this and other issues, and thank you again to our listeners for joining today.  Dr Nath: Thank you so much, Aaron, for that wonderful interview, and I'm extremely proud of all your accomplishments over the last 20 years. You've done an amazing job, and it was such a pleasure to see you and to be able to do this interview with you. Thank you again.  Dr Berkowitz: Thanks. That means a lot. I never would have imagined- we won't say 20, how many, but 20-something years ago as the medical student looking up to you and all your expertise on these infections and all of your research that led to so much of our understanding on these, that I would find myself interviewing you two decades later. So, for all the students listening, you never know where you'll end up, but I appreciate your very kind words.  Dr Nath: That's what we hope for all our students. Thank you so much.  Dr Berkowitz: Thanks again.  Dr Monteith: This is Dr. Teshamae Monteith, Associate Editor of Continuum Audio. If you've enjoyed this episode, you'll love the journal, which is full of in-depth and clinically relevant information important for neurology practitioners. Use the link in the episode notes to learn more and subscribe. AAN members, you can get CME for listening to this interview by completing the evaluation at continpub.com/audioCME. Thank you for listening to Continuum Audio.

Boa terça, angulers! Abrimos o #332 comentando o encontro entre Lula e Trump nos EUA. Mais uma canetada da diplomacia brasileira! No segundo bloco, Alexandre de Moraes suspende aplicação da Lei da Dosimetria até que o STF analise a constitucionalidade. Ainda falamos de Ciro Nogueira, alvo da PF no caso Banco Master. Por fim, o caso Ypê: de risco sanitário à defesa acalorada por bolsonaristas. Sirva-se! Apoie o Angu de Grilo no apoia.se: apoia.se/angudegrilo ou na Orelo: orelo.cc/angudegriloCortes do episódio em vídeo no @angudegrilo no Instagram e Tiktok! Siga, curta e compartilhe! Edição e mixagem: Tico Pro @ticopro_Redes sociais: Claudio Thorne @claudiothorneCortes em vídeo: Nathália Dias Souza @natdiassouza

Today we acknowledge a great man who took one for the team... Darcy Swain dropped the kick-off in Canberra. Nick H returns from holiday to chew the fat with Nath and Nick W, and discuss whether the Aussie sides can turn around a flat run of form. WARNING: A few naughty words said. When the lads come together, the language warning comes up. Something we should probably ponder about at some point.See omnystudio.com/listener for privacy information.

This week it's time for Pokémon: The First Movie. Rob is a lifelong is a lifelong Pokéfan while Nath and Dave are bemused onlookers ready to receive a heartwarming introduction to the world of collecting, training, and trying your best. Which is a shame because what they actually get is an existential nightmare dressed as a children's adventure. What does it mean to be alive? What is the purpose of existing? And what would you do if you have to fight yourself to the death? Join us as we find out!Let us know what you think of this episode by emailing us at redshirtcinemaclub@gmail.com and support us on Patreon at patreon.com/redshirtcinemaclub for access to two bonus episodes per month as well as our newsletter, The Civilian Observer. Hosted on Acast. See acast.com/privacy for more information.

Boa terça, angulers! No primeiro bloco do #331, comentamos a rejeição de Jorge Messias pelo Senado. Pela primeira vez na história, uma indicação para ministro do STF é vetada. Ainda nesse bloco, falamos da derrubada do veto do PL da Dosimetria pelo Congresso. Fim dos tempos. No segundo bloco, explicamos o Desenrola 2.0, novo programa do governo para combater o endividamento de parte da população. Por fim, Lobacabana! O que achamos do show da Shakira no Rio? Sirva-se! Apoie o Angu de Grilo no apoia.se: apoia.se/angudegrilo ou na Orelo: orelo.cc/angudegriloCortes do episódio em vídeo no @angudegrilo no Instagram e Tiktok! Siga, curta e compartilhe! Edição e mixagem: Tico Pro @ticopro_Redes sociais: Claudio Thorne @claudiothorneCortes em vídeo: Nathália Dias Souza @natdiassouza

On the latest PlayStation Access Podcast, we're chatting all about the brilliant SAROS. Join us as Ash, Nath and Alex discuss what makes Housemarque's latest title so special - from the mind-blowing visuals and audio design, to the pulsating combat and mysterious world.PlayStation Access is the official YouTube channel of PlayStation UK - a vibrant, welcoming community celebrating all things PlayStation. Join us for gaming livestreams, list features and in-depth coverage on all your favourite games. Hosted on Acast. See acast.com/privacy for more information.

Boa terça, angulers! Angu #330 no ar e começando pelo atentado nos EUA durante encontro anual da presidência com jornalistas correspondentes. Aproveitamos para atualizar a situação da Guerra com Irã que segue sem acordo de paz e com navios sendo interceptados pelos EUA. No segundo bloco, o relatório da Organização Internacional do Trabalho que aponta os riscos psicossociais de jornadas excessivas, assédio, instabilidade. Ambientes profissionais prejudiciais aumentam riscos de doenças cardiovasculares e transtornos mentais. Por fim, a expectativa pro ShakiCabana e a evocação de uma latinidade feminina que une todas nós. Sirva-se! Apoie o Angu de Grilo no apoia.se: apoia.se/angudegrilo ou na Orelo: orelo.cc/angudegriloCortes do episódio em vídeo no @angudegrilo no Instagram e Tiktok! Siga, curta e compartilhe! Edição e mixagem: Tico Pro @ticopro_Redes sociais: Claudio Thorne @claudiothorneCortes em vídeo: Nathália Dias Souza @natdiassouza

It's time for Super Round... and this week has been super in more ways than one with the game suddenly having a lot more cash! Nick W and Nath chat Super Rugby, the Wallaroos, Sevens rugby and more. OptaRugby: https://www.optaprorugby.com/ WARNING: just one or two naughty words, this one is acceptable for the kids.See omnystudio.com/listener for privacy information.

Boa terça, angulers! Um Angu #329 curtinho (juro!) no feriado. Comentamos o projeto de lei enviado pelo Governo pelo fim da escala 6x1 e redução de jornada de trabalho. No segundo bloco, um micro angu com as atualizações do carnaval: cinco escolas do grupo especial do RJ já anunciaram seus enredos! Na semana passada, foi sorteada a ordem dos desfiles em 2027. Claro, deu tempo de falar de São Jorge. Sirva-se! Apoie o Angu de Grilo no apoia.se: apoia.se/angudegrilo ou na Orelo: orelo.cc/angudegriloCortes do episódio em vídeo no @angudegrilo no Instagram e Tiktok! Siga, curta e compartilhe! Edição e mixagem: Tico Pro @ticopro_Redes sociais: Claudio Thorne @claudiothorneCortes em vídeo: Nathália Dias Souza @natdiassouza

Trell Runs A Train On Val, The Crisis At The Dragons Continues & Nath's Massaging Money Moves!The Political Electorate 13+ Jumpers are back on sale for one week only. Get yours here via: https://hellosport.shop/Neds. Whatever you bet on, Take it to the Neds Level. Visit: https://www.neds.com.au/4 Pines, a brewery born in Manly and enjoyed everywhere. Get their Japanese Lager available here: https://4pinesbeer.com.au/Magic Round Warm Up with 4 Pines at Landers Pocket Brisbane on Thursday May 14th. Get your tickets here - https://sevn.ly/xqSt0OCeGood Day Multivitamin & Day Lyte Electrolytes, it's the least you can do. Use code 'dribblers' for 10% off your order here: https://www.begoodhealth.com.au/Join The Good Day Goers Facebook Group here.The Dragons Stinky SituationThe Bye Round Boys Rip In & Tommy's HammyTommy's Hammy & The Manly Situation The Remaining GamesAFL ScandalEddie V DanaNath Making Comfy Business MovesDribbles & Super Coach Brought To You By Good Day Multi Hosted on Acast. See acast.com/privacy for more information.

Nath Kachoa Na Janau, ਨਾਥ ਕਛੂਅ ਨ ਜਾਨਉ (Sri Guru Granth Sahib Ang 710 Sabad 1905)

Support us on Patreon

Boa terça, angulers! Abrimos o #328 com a nova tentativa frustrada de acordo entre Irã e EUA e, agora, o plano de Trump de bloquear navios que estão pagando o “pedágio” ao Irã para cruzar o estreito de Ormuz. Além disso, comentamos a crise entre Trump e o Papa Leão XIV. No segundo bloco, um apanhado de assuntos na direção das eleições: avaliação do governo; estratégias para aumento de popularidade; Desenrola 2.0; demissão do presidente do INSS. Por fim, os pop-ups da semana: a prisão de Ramagem pelo ICE, nos EUA; a derrota de Orbán, na Hungria; e o Rio de Janeiro que segue sem decisão sobre a eleição para o mandato-tampão. Sirva-se! Apoie o Angu de Grilo no apoia.se: apoia.se/angudegrilo ou na Orelo: orelo.cc/angudegriloCortes do episódio em vídeo no @angudegrilo no Instagram e Tiktok! Siga, curta e compartilhe! Edição e mixagem: Tico Pro @ticopro_Redes sociais: Claudio Thorne @claudiothorneCortes em vídeo: Nathália Dias Souza

Support us on Patreon

Boa terça, angulers! Começamos o #327 anunciando o convidado do Angu ao vivo em São Paulo! Não dá nem pra acreditar! Depois, entramos nos assuntos da semana. Abrimos com a tentativa de cessar-fogo entre EUA e Irã, mediada pelo Paquistão, mas que já foi rejeitada por ambos. No segundo bloco, EUA de novo: a Casa Branca voltou a criticar o Pix e o julgamento, em Los Angeles, que condenou pela primeira vez, Meta e Google por vício em redes sociais. Por fim, as novas regras da Prefeitura do Rio para tráfego de ciclomotores, autopropelidos e bicicletas elétricas e o voo de Artemis II ao redor da Lua. Sirva-se! Apoie o Angu de Grilo no apoia.se: apoia.se/angudegrilo ou na Orelo: orelo.cc/angudegriloCortes do episódio em vídeo no @angudegrilo no Instagram e Tiktok! Siga, curta e compartilhe! Edição e mixagem: Tico Pro @ticopro_Redes sociais: Claudio Thorne @claudiothorneCortes em vídeo: Nathália Dias Souza @natdiassouza

A curious phenomenon emerges this week as we watch 1984's The Neverending Story.It's a favourite from Dave's childhood which Nath and Rob were convinced they'd never seen. The evidence in fact points to them both having watched the film previously and entirely forgotten what happens, which is unfortunately also true of this latest rewatch (something to do with a sad horse and a flying dog, the details are lost to us).Which is all to say that The Neverending Story has a strange energy - a tinge of Euro-weirdness, the half-logic of children elected heroes in the face of magical annihilation, and an episodic structure full of grotesque puppets and special effects. We love it! We've forgotten it. It makes us sad.Let us know what you think of this episode by emailing us at redshirtcinemaclub@gmail.com and support us on Patreon at patreon.com/redshirtcinemaclub for access to two bonus episodes per month as well as our newsletter, The Civilian Observer. Hosted on Acast. See acast.com/privacy for more information.

Boa terça, angulers! Voltamos de férias! Acabou a farra e já abrimos o #326 com adio de Janeiro sem Governo. Cláudio Castro, na eminência de ser cassado pro TSE, renunciou e está inelegível por oito anos. O Estado do Rio está com um governador interino, Ricardo Couto, presidente do TJ-RJ, e precisará convocar novas eleições para um mandato-tampão. No próximo dia 8, o STF decide se as eleições serão diretas ou indiretas. Mais uma vergonha na conta da política fluminense. No segundo bloco, comentamos a pesquisa PENSE, do IBGE, sobre a saúde dos estudantes brasileiros entre 13 e 17 anos. Um panorama profundo sobre os adolescentes e saúde mental, assédio, bullying, drogas, cuidados com saúde, educação sexual. Assunto importantíssimo. De olho nos combustíveis, hein? A alta do diesel estabilizou mas já aumentou mais de 20% desde o início da guerra. Sirva-se!Apoie o Angu de Grilo no apoia.se: apoia.se/angudegrilo ou na Orelo: orelo.cc/angudegriloCortes do episódio em vídeo no @angudegrilo no Instagram e Tiktok! Siga, curta e compartilhe! Edição e mixagem: Tico Pro @ticopro_Redes sociais: Claudio Thorne @claudiothorneCortes em vídeo: Nathália Dias Souza @natdiassouza